» Articles » PMID: 32433053

Long Non-coding RNA Small Nucleolar RNA Host Gene 6 Aggravates Pancreatic Cancer Through Upregulation of Far Upstream Element Binding Protein 1 by Sponging MicroRNA-26a-5p

Overview
Specialty General Medicine
Date 2020 May 21
PMID 32433053
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatic cancer (PC) is a highly deadly malignancy with few effective therapies. We aimed to unmask the role that long non-coding RNA small nucleolar RNA host gene 6 (SNHG6) plays in PC cells by targeting far upstream element binding protein 1 (FUBP1) via microRNA-26a-5p (miR-26a-5p).

Methods: SNHG6 expression was predicted by bioinformatics, followed by verification via reverse transcription quantitative polymerase chain reaction. Then, the interactions among SNHG6, miR-26a-5p, and FUBP1 were detected through online software analysis, dual luciferase reporter assay and RNA pull-down. After that, cells were treated with different small interfering RNAs and/or mimic to determine the interactions among SNHG6, miR-26a-5p, and FUBP1 and their roles in PC cells. Finally, the role of SNHG6 in tumor growth in vivo was evaluated by measuring the growth and weight of transplanted tumors in nude mice. A t-test, one-way and two-way analysis of variance were used for data analysis.

Results: Compared with that in normal tissues, SNHG6 was highly expressed in PC tissues (1.00 ± 0.05 vs. 1.56 ± 0.06, t = 16.03, P < 0.001). Compared with that in human pancreatic duct epithelial cells (HPDE6-C7), SNHG6 showed the highest expression in PANC-1 cells (1.00 ± 0.06 vs. 3.87 ± 0.13, t = 34.72, P < 0.001) and the lowest expression in human pancreatic cancer cells (MIAPaCa-2) (1.00 ± 0.06 vs. 1.41 ± 0.07, t = 7.70, P = 0.0015). Compared with the levels in the si-negative control group, SNHG6 (0.97 ± 0.05 vs. 0.21 ± 0.06, t = 16.85, P < 0.001), N-cadherin (0.74 ± 0.05 vs. 0.41 ± 0.04, t = 8.93, P < 0.001), Vimentin (0.55 ± 0.04 vs. 0.25 ± 0.03, t = 10.39, P < 0.001), and β-catenin (0.62 ± 0.05 vs. 0.32 ± 0.03, t = 8.91, P < 0.001) were decreased, while E-cadherin (0.65 ± 0.06 vs. 1.36 ± 0.07, t = 13.34, P < 0.001) was increased after SNHG6 knockdown or miR-26a-5p overexpression, accompanied by inhibited cell proliferation, migration, and invasion. SNHG6 overexpression exerted the opposite effects. SNHG6 upregulated FUBP1 expression by sponging miR-26a-5p. Silencing SNHG6 blocked the growth of PC in vivo.

Conclusion: Silencing SNHG6 might ameliorate PC through inhibition of FUBP1 by sponging miR-26a-5p, thus providing further supporting evidence for its use in PC treatment.

Citing Articles

Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.

Curcio C, Rosso T, Brugiapaglia S, Guadagnin G, Giordano D, Castellino B Clin Exp Med. 2023; 23(8):5089-5100.

PMID: 37910256 PMC: 10725354. DOI: 10.1007/s10238-023-01236-5.


The Role of lncRNA-miR-26a-mRNA Network in Cancer Progression and Treatment.

Zhu J, Wang L Biochem Genet. 2023; 62(3):1443-1461.

PMID: 37730965 DOI: 10.1007/s10528-023-10475-w.


Microbiome and MicroRNA or Long Non-Coding RNA-Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma.

Izdebska W, Daniluk J, Niklinski J J Clin Med. 2023; 12(17).

PMID: 37685710 PMC: 10488817. DOI: 10.3390/jcm12175643.


Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells Proliferation.

Li X, Yu H, Xu F, Wu Y, Sheng J Biomed Res Int. 2021; 2021:6664519.

PMID: 33954195 PMC: 8063849. DOI: 10.1155/2021/6664519.

References
1.
Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

2.
Gao J, Zeng K, Liu Y, Gao L, Liu L . LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 2019; 12:169-179. PMC: 6309782. DOI: 10.2147/OTT.S184078. View

3.
Deng J, He M, Chen L, Chen C, Zheng J, Cai Z . The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival. PLoS One. 2013; 8(10):e76450. PMC: 3792981. DOI: 10.1371/journal.pone.0076450. View

4.
Batchu R, Gruzdyn O, Qazi A, Kaur J, Mahmud E, Weaver D . Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer. Surgery. 2015; 158(4):981-6. DOI: 10.1016/j.surg.2015.05.019. View

5.
Zhang X, Liu Z, Shu Q, Yuan S, Xing Z, Song J . LncRNA SNHG6 functions as a ceRNA to regulate neuronal cell apoptosis by modulating miR-181c-5p/BIM signalling in ischaemic stroke. J Cell Mol Med. 2019; 23(9):6120-6130. PMC: 6714173. DOI: 10.1111/jcmm.14480. View